Search for:

A primary goal of the ARLG is to train the next generation of researchers who will help reduce the public health threat of antibacterial resistance.

LEARN MORE

Home
About
Publications
News and Events
- Events
- Newsletters
How to Apply
SDMC
Lab Center
Studies
Resources
- For Patients and the Community
- Summary of Results

ARLG

Antibacterial Resistance Leadership Group

The Microbiota and Resistome in Clinical Trials: Opportunities and Challenges

Posted on May 23, 2023 by susan.herron@duke.edu

ARLG Grand Rounds: The Microbiota and Resistome in Clinical Trials: Opportunities and Challenges
May 6, 2022

Melinda M. Pettigrew, PhD
Deputy Dean and Anna M. R. Lauder Professor of Epidemiology
Yale School of Public Health

View the Event Slides

This entry was posted in Past Events. Bookmark the permalink.

← Considerations for the Use of Phages in Clinical Practice

Dissecting The Epidemics of Multidrug-Resistant Organisms: A Focus on Carbapenem-Resistant Klebsiella pneumoniae →

Home
About the ARLG
Publications
About the Laboratory Center
Studies

ARLG is supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number UM1AI104681. The content of this website is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Subscribe to the ARLG newsletter to stay connected

Privacy Statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.